These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 47841)

  • 21. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of distinctive surface antigen on cells transformed by murine sarcoma virus.
    Strouk V; Grundner G; Fenyö EM; Lamon E; Skurzak H; Klein G
    J Exp Med; 1972 Aug; 136(2):344-52. PubMed ID: 5043415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB; Aoki T; Silverman TN
    Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
    Kimura H; Yamaguchi Y
    Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F; MacDonald HR; Shain B
    J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth.
    Guiliani F; Casazza AM; Soranzo C; Di Marco A
    Br J Cancer; 1977 Feb; 35(2):190-8. PubMed ID: 189792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent, cell-mediated cytotoxicity with autochthonous lymphocytes and sera after infection with Moloney sarcoma virus.
    Lamon EW; Hale P; Whitten HD
    J Natl Cancer Inst; 1976 Feb; 56(2):349-55. PubMed ID: 1255765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of Moloney sarcoma virus-induced tumor growth by concanavalin A.
    Davis S; Redmon LW; Pearson GR
    Immunol Commun; 1975; 4(1):29-37. PubMed ID: 1090515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response.
    Pollack S; Nelson K
    Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.